News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
Neoadjuvant treatment with an anthracycline-free regimen in Breast Cancer – Breast International Group
Breast International Group/X
Dec 13, 2024, 15:19

Neoadjuvant treatment with an anthracycline-free regimen in Breast Cancer – Breast International Group

Breast International Group shared a post on X:

“SABCS24.

P3-11-03 poster on results of phase 2 DECRESCENDO study:

Neoadjuvant treatment with an anthracycline-free regimen in patients with HER2-positive, HR-negative, node-negative early breast cancer resulted in a high rate of pCR.”

For more updates, follow OncoDaily.

Anthracycline anthracycline-free Breast Cancer Breast International Group cancer DECRESCENDO study EU4Health HaDEA Jules Bordet Institute neoadjuvant treatment OncoDaily Oncology SABCS24
Special Coverage
Blog
Feb 5, 2025, 00:16
Celebrating Ben Anderson’s Retirement and the Next Phase of Cancer Care Innovation at C/Can
Blog
Feb 5, 2025, 00:14
Joanna Strober: A breakthrough moment for women's healthcare
Blog
Feb 5, 2025, 00:12
Don't miss the opportunity to join the ESO Improving Cancer Outcomes and Leadership course
Blog
Feb 5, 2025, 00:10
Noelene Kotschan: Join Pink Drive in the fight against cancer
Blog
Feb 5, 2025, 00:08
City Cancer Challenge - Where you live and who you are shouldn’t determine the quality of cancer care you receive
Blog
Feb 5, 2025, 00:06
Chris Boshoff: Pfizer’s BRAFTOVI Combination Regimen Significantly Improved PFS and OS in Phase 3 BREAKWATER Trial
Blog
Feb 5, 2025, 00:04
Sandra Demaria: Join Female Leaders in IO at the 7th Annual SITC WIN Leadership Institute
Blog
Feb 5, 2025, 00:03
Tanja Obradovic: How Biotech companies approach oncology drug development and pipeline building/management
Science
Feb 5, 2025, 00:00
Elvina Almuradova: PTC significantly prolongs OS in patients with HER2+ metastatic breast cancer
Blog
Feb 4, 2025, 23:58
Emad Shash: Enhancing sustainable development in Egypt through scientific research and innovation
Blog
Feb 4, 2025, 23:57
Wafaa Rashed: Your Voice Matters in Shaping Maternal-Fetal Genomics Policy
Blog
Feb 4, 2025, 23:30
E. Shyam P. Reddy: How cancer ‘poisons’ the immune system